Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Insulin: early-phase trial registry
3 of 7 indexed Insulin trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 3 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Insulin: 7 US clinical trials tracked, 3 recruiting.
Insulin is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Pennington Biomedical Research Center, running 1 of these trials.
Enrollment posture brief
Registry condition insulin
OPEN 3 | RECR 43% | LATE 0 | EARLY 3 | RANK #2497 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adrenoleukodystrophy (43% recruiting · 7 trials)
Insulin lists 3 open slots (43% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Insulin on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Insulin is recruiting below its size-band peers.
3 of 7 indexed trials (42.9%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Insulin trials is spread across many organizations.
Pennington Biomedical Research Center accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.
-
Most Insulin trials plan to enrol fewer than 100 people.
Median target enrolment is 65 among the 7 trials that report a genuine target (sentinel values excluded). 5 of those (71.4%) plan for fewer than 100 participants.
-
Insulin research is mostly interventional.
5 interventional and 2 observational studies make up this index (71.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
30 Day Insulin Balance Metabolic Health Optimization Protocol
Efforia
NCT07478497
Assessing the Value of Avocados on Glycemic Control in Type 2 Diabetes
Pennington Biomedical Research Center
NCT05958368
Evaluation of a Novel Insulin Sensitizer in People With Type 1 Diabetes
University of Virginia
NCT07186660
Safety and Efficacy of Combining Intranasal Insulin & Acute Exercise
Michigan State University
NCT04292535
Insulin Dosing Practices in Persons With Diabetes on Multiple Daily Injections
Joslin Diabetes Center
NCT02914730
Effect of High-Legume Diet on Colorectal Cancer Risk
National Cancer Institute (NCI)
NCT00339469
Effect of Diet on Vascular Disease in Pre-Menopausal Women
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT00484861
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Insulin records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Insulin trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Insulin page
7 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Insulin trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Pennington Biomedical Research Center sponsors the most Insulin trials on record, review their full trial history before evaluating a specific study. See Pennington Biomedical Research Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Insulin condition card totals 7 registered trials; most-linked intervention LIFE; top US site state Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.